Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials

Neoadjuvant chemoradiotherapy (NCRT) plus radical esophagectomy is currently the standard treatment for resectable esophageal or gastroesophageal junction (GEJ) carcinoma. The aim of this study is to evaluate the efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or GEJ carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jie, Leng, Xuefeng, Gao, Binyang, Wang, Bo, Zhang, Hanlin, Wu, Lei, Ma, Jiabao, Tan, Yan, Peng, Lin, Han, Yongtao, Wang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800859/
https://www.ncbi.nlm.nih.gov/pubmed/36591306
http://dx.doi.org/10.3389/fimmu.2022.1041233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800859/
https://www.ncbi.nlm.nih.gov/pubmed/36591306
http://dx.doi.org/10.3389/fimmu.2022.1041233

Ejemplares similares